Search research articles
Contact Us
Filters
Showing results (1-10 of 92) with videos related to
Page
of 10
Sort By:
Giornale Italiano Di Cardiologia (2006)
|
December 24, 2025
[Therapeutic plans and AIFA notes in cardiology: the need for a comprehensive review and update]
Marcello Galvani, Nicola Magrini
Recenti Progressi in Medicina
|
July 19, 2022
[Harmonizing development, approval and access of drugs for rare diseases in Europe.]
Enrico Costa, Nicola Magrini
BMJ (Clinical Research Ed.)
|
September 15, 2007
Direct to consumer advertising of drugs in Europe
Nicola Magrini, Maria Font
Pharmacoepidemiology and Drug Safety
|
January 7, 2003
New approaches to analysing prescription data and to transfer pharmacoepidemiological and evidence-based reports to prescribers
Antonio Addis, Nicola Magrini
BMJ (Clinical Research Ed.)
|
May 31, 2003
Information from drug companies and opinion leaders
Alessandro Liberati, Nicola Magrini
Recenti Progressi in Medicina
|
March 15, 2014
[DSM-5: a diagnosis and a drug should not be denied to anyone]
Francesco Nonino, Nicola Magrini
American Journal of Respiratory and Critical Care Medicine
|
July 11, 2024
MIST-3 Is Well Worth an Echo!
Claudia Ravaglia, Nicola Magrini, Venerino Poletti
Social Science & Medicine (1982)
|
December 5, 2006
Social marketing: should it be used to promote evidence-based health information?
Giulio Formoso, Anna Maria Marata, Nicola Magrini
BMJ (Clinical Research Ed.)
|
November 18, 2024
Celebrating Alessandro Liberati, his vision, books, journals, libraries, "anti libraries," and radical thinking
Nicola Magrini, Luca de Fiore, Richard Smith
European Journal of Internal Medicine
|
April 25, 2015
Choosing ACE-inhibitors instead of sartans: encouraging results of an evidence-based policy in Emilia-Romagna, Italy
Giulio Formoso, Nicola Magrini, Anna Maria Marata
Page
of 10
Search research articles
Search
Showing results (1-10 of 92) with videos related to
Sort By:
Page
of 10
Giornale Italiano Di Cardiologia (2006)
|
December 24, 2025
[Therapeutic plans and AIFA notes in cardiology: the need for a comprehensive review and update]
Marcello Galvani, Nicola Magrini
Recenti Progressi in Medicina
|
July 19, 2022
[Harmonizing development, approval and access of drugs for rare diseases in Europe.]
Enrico Costa, Nicola Magrini
BMJ (Clinical Research Ed.)
|
September 15, 2007
Direct to consumer advertising of drugs in Europe
Nicola Magrini, Maria Font
Pharmacoepidemiology and Drug Safety
|
January 7, 2003
New approaches to analysing prescription data and to transfer pharmacoepidemiological and evidence-based reports to prescribers
Antonio Addis, Nicola Magrini
BMJ (Clinical Research Ed.)
|
May 31, 2003
Information from drug companies and opinion leaders
Alessandro Liberati, Nicola Magrini
Recenti Progressi in Medicina
|
March 15, 2014
[DSM-5: a diagnosis and a drug should not be denied to anyone]
Francesco Nonino, Nicola Magrini
American Journal of Respiratory and Critical Care Medicine
|
July 11, 2024
MIST-3 Is Well Worth an Echo!
Claudia Ravaglia, Nicola Magrini, Venerino Poletti
Social Science & Medicine (1982)
|
December 5, 2006
Social marketing: should it be used to promote evidence-based health information?
Giulio Formoso, Anna Maria Marata, Nicola Magrini
BMJ (Clinical Research Ed.)
|
November 18, 2024
Celebrating Alessandro Liberati, his vision, books, journals, libraries, "anti libraries," and radical thinking
Nicola Magrini, Luca de Fiore, Richard Smith
European Journal of Internal Medicine
|
April 25, 2015
Choosing ACE-inhibitors instead of sartans: encouraging results of an evidence-based policy in Emilia-Romagna, Italy
Giulio Formoso, Nicola Magrini, Anna Maria Marata
Page
of 10